ANTI NUCLEAR ANTIBODY - IFA (QUALITATIVE)

The Anti-Nuclear Antibody (ANA) IFA Qualitative Test is a specialized blood test that detects the presence or absence of Anti-Nuclear Antibodies (ANA) using the Indirect Immunofluorescence Assay (IFA) method. ANAs are autoantibodies that mistakenly target components of the cell nucleus and are commonly associated with a variety of autoimmune diseases.

The ANA IFA Qualitative Test is widely used as an initial screening test for Systemic Lupus Erythematosus (SLE), Sjögren's syndrome, Systemic Sclerosis (Scleroderma), Mixed Connective Tissue Disease (MCTD), and other autoimmune connective tissue disorders. A qualitative result reports whether ANA antibodies are positive or negative. If the result is positive, additional tests such as ANA Titer, ANA Pattern, or Extractable Nuclear Antigen (ENA) Panel may be recommended for further evaluation.

Benefits of the Test

• Detects Anti-Nuclear Antibodies using the gold-standard IFA method.
• Helps screen for autoimmune connective tissue diseases.
• Supports early diagnosis of systemic autoimmune disorders.
• Assists physicians in selecting appropriate follow-up testing.
• Helps evaluate patients with unexplained autoimmune symptoms.
• Supports diagnosis alongside clinical examination and laboratory findings.

Why Doctors Recommend This Test

Doctors may recommend the ANA IFA Qualitative Test if you experience symptoms suggestive of an autoimmune disease, including:

• Persistent fatigue
• Joint pain or swelling
• Muscle aches
• Skin rashes, especially after sun exposure
• Unexplained fever
• Dry eyes or dry mouth
• Raynaud's phenomenon
• Hair loss
• Unexplained inflammation or positive autoimmune screening results

The test is commonly ordered with ENA Panel, Anti-dsDNA, Anti-Sm, Anti-Ro (SSA), Anti-La (SSB), Complement C3/C4, ESR, CRP, and Complete Blood Count (CBC).

Preparation Before Test

• No fasting is required.
• Continue regular medications unless instructed otherwise by your physician.
• Inform your healthcare provider about autoimmune diseases, current medications, and recent infections.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 2–5 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected autoimmune diseases.
• Patients with unexplained joint pain, fatigue, or skin rashes.
• Individuals with positive autoimmune screening results.
• Patients referred by rheumatologists or internal medicine specialists.
• Individuals requiring screening for connective tissue disorders.

Patient-Friendly Summary

The Anti-Nuclear Antibody (ANA) IFA Qualitative Test is a blood test that checks whether Anti-Nuclear Antibodies are present in your blood. These antibodies may develop when the immune system mistakenly attacks healthy cells. A positive ANA test may be associated with autoimmune diseases such as Systemic Lupus Erythematosus (SLE), Sjögren's syndrome, Systemic Sclerosis, and other connective tissue disorders. However, a positive ANA result alone does not confirm a diagnosis and must be interpreted along with your symptoms, medical history, and additional laboratory tests. This safe and reliable blood test requires only a blood sample and generally does not require fasting.